A new strategy to overcome tumour-induced immunosuppression
Researchers have found that blocking key enzymes could boost anti-cancer T cell responses and resistance to immunosuppression.
List view / Grid view
Researchers have found that blocking key enzymes could boost anti-cancer T cell responses and resistance to immunosuppression.
Scientists have discovered antibodies that are effective against many different COVID-19 variants.
Vaccinating mice with this universal flu candidate induced broad neuraminidase inhibition, M2 ectodomain specific antibodies and T cell immune responses.
Researchers have developed a safe and versatile platform to increase the thermal stability of vaccines and improve their transportability.
Researchers have designed a COVID-19 vaccine to be less sensitive to mutations and equipped for future strains.
Scientists have found that unconventional T cells migrate from tissue into the lymph nodes and influence immune responses there.
Researchers have succeeded in developing organoids that contain mature Paneth cells, which were not present in the previous human small intestinal organoids.
The drug candidate, JSF-2659, has been developed to be administered orally, and could be a game changer in treating gonorrhoea.
Researchers have identified latent stem cells that could respond to spinal cord injuries.
The findings by Massachusetts General Hospital could point to a potential target to treat Crohn’s disease.
An animal study has shown that a modified vaccine for tuberculosis could treat bladder cancer whilst minimising side effects.
A recent genomic surveillance study has demonstrated the value of genomics to inform vaccine design and highlight the challenge posted by shapeshifting bacteria.
Scientists have identified and synthesised a small molecule that could be a more accessible and affective alternative to an antibody that treats a wide range of cancers.
The new RSV vaccine formulation protected newborn mice against infection and evoked strong responses in immune cells from human newborns.
Using cryo-electron microscopy, researchers have captured the structure of a membrane-bound T-cell receptor complex with bound antigen.